Ciclosporina oral en microemulsión para el tratamiento de la colitis ulcerativa crónica idiopática grave refractaria a esteroides intravenosos; experiencia en dos casos

Statistics

Oral cyclosporine microemulsion for the treatment of severe chronic idiopathic ulcerative colitis refractory to intravenous steroids: experience in two cases

E. Coss-Adamea, J. Barahona-Garridoa, JK. Yamamoto-Furushoa

a Clínica de Enfermedad Inflamatoria Intestinal, Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, D. F. Universidad Nacional Autónoma de México, México, D. F.

Read

13935

Times
was read the article

3729

Total PDF

10206

Total HTML

Share statistics

Article information

ISSN: 03750906
Original language: Spanish

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	19	3	22
2025 5	118	11	129
2025 4	103	23	126
2025 3	104	10	114
2025 2	94	20	114
2025 1	112	19	131
2024 12	91	31	122
2024 11	125	23	148
2024 10	58	19	77
2024 9	88	24	112
2024 8	78	27	105
2024 7	93	60	153
2024 6	108	61	169
2024 5	130	27	157
2024 4	94	48	142
2024 3	109	48	157
2024 2	97	54	151
2024 1	97	36	133
2023 12	102	32	134
2023 11	126	56	182
2023 10	140	45	185
2023 9	137	67	204
2023 8	83	34	117
2023 7	119	30	149
2023 6	110	30	140
2023 5	81	41	122
2023 4	77	14	91
2023 3	188	34	222
2023 2	78	31	109
2023 1	82	42	124
2022 12	94	44	138
2022 11	129	58	187
2022 10	100	31	131
2022 9	64	46	110
2022 8	71	62	133
2022 7	73	40	113
2022 6	73	44	117
2022 5	74	49	123
2022 4	72	75	147
2022 3	75	68	143
2022 2	75	45	120
2022 1	104	48	152
2021 12	86	62	148
2021 11	76	75	151
2021 10	74	71	145
2021 9	71	64	135
2021 8	82	69	151
2021 7	84	67	151
2021 6	112	67	179
2021 5	99	90	189
2021 4	203	115	318
2021 3	92	42	134
2021 2	113	42	155
2021 1	81	30	111
2020 12	111	11	122
2020 11	54	35	89
2020 10	87	36	123
2020 9	60	37	97
2020 8	85	25	110
2020 7	45	21	66
2020 6	58	23	81
2020 5	71	20	91
2020 4	57	15	72
2020 3	61	20	81
2020 2	61	20	81
2020 1	40	16	56
2019 12	57	28	85
2019 11	61	27	88
2019 10	59	14	73
2019 9	43	24	67
2019 8	44	23	67
2019 7	81	16	97
2019 6	93	12	105
2019 5	125	16	141
2019 4	70	19	89
2019 3	30	8	38
2019 2	39	23	62
2019 1	49	19	68
2018 12	40	22	62
2018 11	67	36	103
2018 10	98	29	127
2018 9	33	14	47
2018 8	10	7	17
2018 7	27	14	41
2018 6	32	14	46
2018 5	22	13	35
2018 4	29	4	33
2018 3	22	4	26
2018 2	36	6	42
2018 1	18	4	22
2017 12	19	4	23
2017 11	16	3	19
2017 10	22	4	26
2017 9	20	11	31
2017 8	32	6	38
2017 7	36	23	59
2017 6	44	6	50
2017 5	20	9	29
2017 4	25	16	41
2017 3	16	8	24
2017 2	11	2	13
2017 1	16	6	22
2016 12	26	12	38
2016 11	33	7	40
2016 10	62	11	73
2016 9	80	10	90
2016 8	32	9	41
2016 7	21	10	31
2016 6	1	14	15
2016 5	1	10	11
2016 4	0	16	16
2016 3	2	0	2
2016 2	2	17	19
2015 12	4	0	4
2015 11	1	14	15
2015 10	0	14	14
2015 9	1	0	1
2015 8	3	15	18
2015 7	1	0	1
2015 6	10	4	14
2015 5	59	21	80
2015 4	60	45	105
2015 3	49	22	71
2015 2	49	16	65
2015 1	63	14	77
2014 12	47	5	52
2014 11	53	9	62
2014 10	46	16	62
2014 9	60	11	71
2014 8	56	19	75
2014 7	40	20	60
2014 6	55	18	73
2014 5	64	16	80
2014 4	43	12	55
2014 3	69	16	85
2014 2	68	21	89
2014 1	82	13	95
2013 12	70	18	88
2013 11	97	20	117
2013 10	89	23	112
2013 9	65	15	80
2013 8	47	17	64
2013 7	41	2	43
2013 6	11	0	11
2013 5	18	0	18
2013 4	15	0	15
2013 3	5	0	5
2013 2	3	0	3
2013 1	1	0	1
2012 12	6	0	6
2012 11	2	0	2
2012 10	3	0	3
2009 9	1020	0	1020

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter